Ophthotech Corporation reported a net loss of $13.2 million, or $0.37 per diluted share, in the second quarter of 2018, compared to a net loss of $22.2 million, or $0.62 per share, for 2017’s second quarter, the company announced in a press release.
General and administrative costs decreased from $8.6 million in 2017’s second quarter to $6.3 million for the same period of 2018, while research and development costs decreased from $15.7 million to $8.5 million.
The company has $146 million in cash and cash equivalents as of June 20, 2018.
Uncategorized